LOW
56
3
COST
66
6
TSN
42
4
HSIC
45
11
VTR
50
3
CA
22
12
MET
60
2
SWKS
39
-6
WEC
53
8
MCO
77
7
AON
60
4
PSA
60
5
AEE
58
7
RCL
87
4
PPL
57
10
CFG
68
-2
NEM
42
10
EQIX
65
3
MS
79
2
HCP
76
2
LOW
56
3
COST
66
6
TSN
42
4
HSIC
45
11
VTR
50
3
CA
22
12
MET
60
2
SWKS
39
-6
WEC
53
8
MCO
77
7
AON
60
4
PSA
60
5
AEE
58
7
RCL
87
4
PPL
57
10
CFG
68
-2
NEM
42
10
EQIX
65
3
MS
79
2
HCP
76
2
Financhill
Back

Cellectar Biosciences Vs. Marinus Pharmaceuticals Industry Stock Comparison

Sell
46

CLRB
Cellectar Biosciences

Last Price:
2.13
Seasonality Move:
-2.36%
Sell
33

MRNS
Marinus Pharmaceuticals

Last Price:
0.35
Seasonality Move:
14.27%
Sell
46
Cellectar Biosciences (CLRB) is a Sell

Is Cellectar Biosciences a Buy, Sell or Hold?

  • The current Cellectar Biosciences [CLRB] share price is $2.12. The Score for CLRB is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • CLRB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Marinus Pharmaceuticals (MRNS) is a Sell

Is Marinus Pharmaceuticals a Buy, Sell or Hold?

  • The current Marinus Pharmaceuticals [MRNS] share price is $0.35. The Score for MRNS is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • MRNS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CLRB Stock Price Chart

What is Cellectar Biosciences's stock price today?

  • The Cellectar Biosciences share price today is $2.12
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CLRB is experiencing buying pressure, which is a positive indicator for future bullish movement.

MRNS Stock Price Chart

What is Marinus Pharmaceuticals's stock price today?

  • The Marinus Pharmaceuticals share price today is $0.35
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRNS is experiencing slight selling pressure.

CLRB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 55.97 Buy
Chaikin Money Flow: 143251 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.04 - 2.12) Buy
Bollinger Bands (100): (1.96 - 2.46) Sell

MRNS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.35 Sell
Relative Strength Index (14 RSI): 25.32 Sell
Chaikin Money Flow: -394884 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.36 - 1.8) Sell
Bollinger Bands (100): (0.91 - 1.73) Sell

CLRB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.06 Buy
20-day SMA: 2.07 Buy
50-day SMA: 2.09 Buy
200-day SMA: 2.84 Sell
8-day EMA: 2.07 Buy
20-day EMA: 2.07 Buy
50-day EMA: 2.11 Buy
200-day EMA: 2.49 Sell

MRNS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.33 Buy
20-day SMA: 0.91 Sell
50-day SMA: 1.32 Sell
200-day SMA: 3.54 Sell
8-day EMA: 0.41 Sell
20-day EMA: 0.75 Sell
50-day EMA: 1.15 Sell
200-day EMA: 3.01 Sell

Cellectar Biosciences Earnings Growth & CLRB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.08 per share, and an increase next year of $1.21 per share.

Marinus Pharmaceuticals Earnings Growth & MRNS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.62 per share, and an increase next year of $1.17 per share.

Cellectar Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Marinus Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):